RESTEPS for Early Psychosis

(AFSP RESTEPS Trial)

AR
BG
Overseen ByBrandon Gaudiano, PhD
Age: < 65
Sex: Any
Trial Phase: Academic
Sponsor: Butler Hospital
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

A mental health program, called RESTEPS, will be developed for patients with early psychosis being treated in outpatient mental health centers, focusing on reducing suicide risk by targeting mental health stigma and social support. Youth (n = 35) with psychosis and current/past suicidal thoughts or behaviors will be recruited from community mental health centers to complete an initial open trial examining the feasibility and acceptability of RESTEPS, an 8-session intervention. Participants will be assessed at baseline, mid-intervention, post-intervention, and at a 6-month follow-up.

Who Is on the Research Team?

AR

Ana Rabasco, PhD

Principal Investigator

Butler Hospital

Are You a Good Fit for This Trial?

This trial is for young people with early psychosis who have had suicidal thoughts or behaviors, and are receiving care at community mental health centers. Participants should be able to attend outpatient sessions.

Inclusion Criteria

Ability to speak and read English sufficiently to complete study procedures
My psychotic symptoms started less than 2 years ago or I am in early psychosis treatment.
Suicide risk defined as any lifetime suicide attempt or suicidal ideation (yes to Questions 1-5 on the Columbia Suicide Severity Rating Scale or C-SSRS)
See 3 more

Exclusion Criteria

Involuntary hospitalization at the time of consent
I do not have severe psychotic symptoms that stop me from understanding or joining the study.
My psychotic symptoms are only caused by drugs, withdrawal, or a medical condition.

What Are the Treatments Tested in This Trial?

Interventions

  • RESTEPS

Trial Overview

The study is testing RESTEPS, an 8-session mental health program designed to reduce suicide risk by addressing stigma and improving social support in youth with early psychosis. The program's usefulness and acceptability will be evaluated.

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: RESTEPSExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Butler Hospital

Lead Sponsor

Trials
133
Recruited
16,700+

American Foundation for Suicide Prevention

Collaborator

Trials
36
Recruited
10,500+